Method for processing fluorescence immunochromatography test data
Through the combination of basic chromatography test and specific chromatography test, multiple abnormal bodies are identified and analyzed, which solves the problems of high cost and low accuracy in detecting multiple abnormal bodies in the prior art, and realizes efficient abnormal body detection and analysis .
Patent Information
- Application Number
- CN202411436903.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-15
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-10-15
AI Technical Summary
Existing fluorescence immunochromatography testing methods cannot effectively detect multiple abnormal bodies, which increases detection cost and may lead to false positive errors, reducing detection accuracy and sensitivity.
Using a combination of basic chromatography test and specific chromatography test, pre-detect the solution through basic chromatography test, identify abnormal bodies, and dilute specific chromatography test according to the abnormal body type and concentration to analyze the abnormal body type and concentration to reduce false Positive, improve detection accuracy.
Through the combination of basic chromatography test and specific chromatography test, the detection and analysis cost is reduced, the detection accuracy is improved, false positive errors are reduced, and the detection needs of various abnormal bodies are met.
Smart Images

Figure CN118962125A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of chromatography test data processing, and in particular to a method for processing fluorescence immunochromatography test data. Background Art
[0002] Fluorescence immunochromatography is an efficient and rapid method for detecting specific pathogens in biological samples, and has been widely used in medicine, agriculture and other fields. With the continuous development of fluorescence immunochromatography technology, the amount of data generated by the test is increasing, and how to effectively process and analyze this data has become increasingly important.
[0003] Prior art, such as the invention patent application with announcement number CN107389625B, discloses a method for processing fluorescent immunochromatographic test data, including providing an immunochromatographic test strip, an excitation light source and a stimulated light reading device, controlling the light spot through the control device so that the light spot moves along the length direction of the chromatography test strip, and performing data processing on the signal intensity corresponding to the effective light spot, thereby obtaining the test result of the immunochromatographic test strip. The method of the present invention eliminates the loss of samples between batches introduced on the quality control line, the difference in the amount of sample added between batches, and some interference factors in the antibody labeling process, so that the final data results have reasonable physical meaning and higher sensitivity.
[0004] With respect to the above scheme, the present invention finds that the above technology has at least the following technical problems: on the one hand, the above scheme is only a method of detecting one abnormal body through immunochromatographic test paper, without first pre-detecting the solution to be detected. If a solution to be detected has multiple abnormal bodies to be detected, the method needs to test the solutions to be tested one by one, which increases the detection and analysis costs. On the other hand, the above scheme only detects a single solution, without considering the influence of multiple abnormal bodies on the chromatographic test paper, which is easy to cause false positives, affecting the detection accuracy, easily collecting erroneous data, and reducing the sensitivity. Summary of the invention
[0005] In view of the above-mentioned technical deficiencies, the object of the present invention is to provide a method for processing fluorescent immunochromatography test data.
[0006] In order to solve the above technical problems, the present invention adopts the following technical solutions: The present invention provides a method for processing fluorescent immunochromatography test data, comprising the following steps: Step 1, basic chromatography test: perform basic chromatography test on each test object to obtain a fluorescence image of each solution, and then collect basic chromatography information of each solution from the fluorescence image of each solution, analyze the basic chromatography information of each solution to obtain each abnormal solution, and identify each abnormal body of each abnormal solution from each abnormal solution.
[0007] Step 2, specific chromatography test: according to each abnormal body of each abnormal solution, set up the initial specific chromatography test, collect each specific test data of the standard concentration of each abnormal solution, and then determine whether a dilution specific chromatography test is needed. When performing a dilution specific chromatography test, collect each specific test data of each diluted solution of each abnormal solution, and analyze each specific test data of each diluted solution of each abnormal solution according to the solution-specific model to obtain the type of abnormal body and abnormal body concentration of each abnormal solution.
[0008] Step 3: Chromatographic data analysis: Obtain basic solution data from the database, and analyze the basic solution data, the type of abnormal body and the concentration of abnormal body in each abnormal solution according to the solution abnormality model to determine whether an early warning is needed.
[0009] Preferably, the specific test data of each dilution of each abnormal solution are analyzed, and the specific analysis results are as follows: the specific test data of each dilution of each abnormal solution include each abnormal body of each dilution of each abnormal solution and the spot size corresponding to each abnormal body, each abnormal body of each dilution of each abnormal solution is counted to obtain the number of occurrences of each abnormal body of each abnormal solution, the size of each specific spot of each dilution of each solution is substituted into the calculation formula to obtain the concentration of each abnormal body of each dilution of each abnormal solution, the standard concentration corresponding to each abnormal body is obtained from the database, if the concentration of a certain abnormal body of a certain dilution of a certain solution is greater than the standard concentration, it indicates that the concentration of the abnormal body of the dilution of the solution is high concentration, and the number of occurrences of high concentration of each abnormal body of each abnormal solution is obtained by statistics.
[0010] The number of occurrences of each abnormal body and the number of high concentration occurrences of each abnormal solution are input into the solution-specific model to obtain the output results of each abnormal solution. If the output result of each abnormal solution is 1, it indicates that the dilution-specific test of the abnormal body of the abnormal solution is accurate. If the output result is 0, it indicates that the dilution-specific test of the abnormal body of the abnormal solution is inaccurate, and the dilution solution is replaced to continue the dilution-specific chromatography test.
[0011] Preferably, the basic data of the solution, the type of abnormal body and the concentration of the abnormal body of each abnormal solution are analyzed, and the specific analysis process is as follows: the basic data of the solution includes the standard concentration and maximum concentration corresponding to each abnormal body, and the standard concentration corresponding to each abnormal body is input into the solution abnormal model to obtain the output result of each solution. If the output result of a solution is 1, and the concentration of each abnormal body of the solution is less than the corresponding maximum concentration of each abnormal body, it indicates that the solution meets the requirements. If the output result of a solution is 0, or the concentration of a certain abnormal body of the solution is greater than or equal to the corresponding maximum concentration of each abnormal body, it indicates that the solution is abnormal and a warning is issued.
[0012] The beneficial effects of the present invention are as follows: 1. The present invention first performs a basic chromatography test, performs a basic chromatography test on each test object, obtains a fluorescence image of each solution, and then collects basic chromatography information of each solution from the fluorescence image of each solution, and then performs a specific chromatography test. According to each abnormal body of each abnormal solution, an initial specific chromatography test is set, and each specific test data of the standard concentration of each abnormal solution is collected, and then it is determined whether a dilution specific chromatography test is required. When a dilution specific chromatography test is required, each specific test version data of each diluted solution of each abnormal solution is collected, and according to a solution-specific model, each specific test version data of each diluted solution of each abnormal solution is analyzed to obtain the abnormal body type and abnormal body concentration of each abnormal solution, and then the basic data of each solution and the abnormal body type and abnormal body concentration of each abnormal solution are analyzed to determine whether an early warning is required. The present invention pre-detects each solution through a basic chromatography test, and obtains each abnormal solution and each abnormal body of each abnormal solution according to the basic chromatography information of each solution, thereby meeting the detection requirements for multiple abnormal body solutions and reducing the cost of subsequent detection and analysis.
[0013] 2. The present invention compares the analysis results of the initial specific chromatography test data with the analysis results of the basic chromatography test data to determine whether the initial specific chromatography test data is accurate. If accurate, the initial specific chromatography test data is recorded as the specific chromatography test data. If inaccurate, a diluted specific chromatography test is performed and the analysis results of the diluted specific chromatography test are recorded as the specific chromatography test data. The present invention reduces the probability of false positives and increases the analysis accuracy by analyzing the detection data of a variety of dilution solutions. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0015] Figure 1 The present invention is a schematic flow chart of the steps for implementing the method. DETAILED DESCRIPTION
[0016] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0017] according to Figure 1As shown, the present invention provides a method for processing fluorescent immunochromatography test data, comprising the following steps: Step 1, basic chromatography test: performing basic chromatography test on each test object to obtain a fluorescence image of each solution, and then collecting basic chromatography information of each solution from the fluorescence image of each solution, analyzing the basic chromatography information of each solution to obtain each abnormal solution, and identifying each abnormal body of each abnormal solution from each abnormal solution.
[0018] In a specific embodiment, the basic chromatographic information of each solution is collected, and the specific collection process is as follows: the basic chromatographic information of each solution includes the distance and fluorescence brightness of each light spot in each solution.
[0019] The types of each analyte are obtained from the database, and the fixed plate for detecting the antigen is selected according to the type of each analyte. Each analyte is made into a solution, and then part of the solution of each analyte is washed into the fixed plate. After chromatography, the fluorescence image of each basic chromatography solution is obtained through a fluorescence observation device, and the basic chromatography information of each solution is obtained from the fluorescence image of each basic chromatography solution.
[0020] It should be noted that the analyte refers to the item to be tested, such as blood, food or medicine. Different analytes require different antigens to be tested. At the same time, if the antigen to be tested has been obtained, there is no need to perform basic chromatography tests and specific chromatography tests can be performed directly.
[0021] The fluorescence image of each basic chromatography solution is obtained by fluorescence recognition technology to obtain the distance and fluorescence brightness of each light spot to the test line. The shortest distance from each light spot to the test line is selected and recorded as the distance of each light spot, thereby obtaining the distance and fluorescence brightness of each light spot in each solution.
[0022] It should be noted that the fluorescence recognition technology identifies each fluorescent spot by the brightness of each pixel on the fluorescence image. The shortest distance is the movement distance of the antigen, and different antigens have different diffusion distances on the fixative.
[0023] In a specific embodiment, the basic chromatography information of each solution is analyzed, and the specific analysis process is as follows: the fluorescence brightness and distance of each light spot of the standard solution are obtained from the database, and the fluorescence brightness and distance of each light spot of the standard solution are substituted into the calculation formula and , get the brightness deviation value between the x-ray spots of the standard solution and Distance deviation value, x is the spot number, , , and are the fluorescence brightness and distance of the light spot x, and They are the fluorescence brightness and distance of each light spot of the standard solution. If the brightness deviation value of a pair of light spots of the standard solution is less than the preset light spot deviation value and the distance deviation value is less than the preset distance deviation value, it indicates that the pair of light spots of the standard solution are the same type of normal light spots. In this way, various types of normal light spots are obtained. The fluorescence brightness and distance of each light spot of the standard solution are statistically analyzed to obtain the fluorescence brightness and distance of each type of normal light spot.
[0024] It should be noted that the preset spot deviation value and the preset distance deviation value are set by the staff respectively, for example, the preset spot deviation value is 0.13 and the preset distance deviation value is 0.11.
[0025] The maximum fluorescence brightness and the minimum fluorescence brightness of each type of normal light spot are recorded as the upper limit and the lower limit of the fluorescence brightness interval, respectively, to obtain the fluorescence brightness interval of each type of normal light spot. The shortest distance and the minimum distance of each type of normal light spot are recorded as the upper limit and the lower limit of the distance interval, respectively, to obtain the distance interval of each type of normal light spot. If the fluorescence brightness of a certain light spot does not belong to the fluorescence brightness interval of various types of normal light spots, or the fluorescence brightness of the light spot does not belong to the distance interval of various types of normal light spots, it indicates that the light spot is a specific light spot. If a certain light spot of a certain solution is a specific light spot, then the solution is recorded as an abnormal solution, and the fluorescence brightness interval of each type of specific light spot is obtained from the database. If the fluorescence brightness of a certain light spot of an abnormal solution belongs to the fluorescence brightness interval of a certain type of specific light spot, it indicates that the abnormal solution has an abnormal body corresponding to the specific light spot, thereby obtaining each abnormal body of each abnormal solution.
[0026] It should be noted that the abnormal body is the object of the fluorescent immunochromatography test, such as viruses or bacteria, and the abnormal body is numbered as g. The abnormal body can bind to the corresponding antibody on the fixed plate, and the combined body can react with the fluorescent reagent to produce fluorescence. The light spot is the combination of the fluorescently labeled abnormal body and the corresponding antibody. When the test solution contains any abnormal body, it indicates that the test solution is an abnormal solution. For example, if the fluorescence brightness range of antibody g in the corresponding specific light spot is 6-8, if the brightness range of light spot c of solution a is 7, it indicates that solution a contains The antibody corresponds to the abnormal body g, which indicates that solution a is an abnormal solution.
[0027] Step 2, specific chromatography test: according to each abnormal body of each abnormal solution, set up the initial specific chromatography test, collect each specific test data of the standard concentration of each abnormal solution, and then determine whether a dilution specific chromatography test is needed. When performing a dilution specific chromatography test, collect each specific test data of each diluted solution of each abnormal solution, and analyze each specific test data of each diluted solution of each abnormal solution according to the solution-specific model to obtain the type of abnormal body and abnormal body concentration of each abnormal solution.
[0028] In a specific embodiment, the initial specific chromatography test is set up, and the specific setting process is as follows: each abnormal solution is diluted with a preset dilution ratio to obtain a standard concentration dilution solution of each abnormal solution, and a corresponding antigen fixing plate is selected according to each abnormal body of each abnormal solution to obtain various types of antigen fixing plates for each abnormal solution, and the standard concentration dilution solution of each abnormal solution is flowed into the corresponding various types of antigen fixing plates to obtain various types of antigen fluorescence images of each abnormal solution.
[0029] In a specific embodiment, the determination of whether the specific chromatography test needs to be diluted is specifically determined as follows: each specific test data of the standard concentration of each abnormal solution includes the fluorescence brightness and distance of each light spot in each antigen fluorescence image of each standard concentration abnormal solution. If the fluorescence brightness of any light spot in a certain antigen fluorescence image belongs to the fluorescence brightness interval corresponding to the antigen, and the distance of the light spot belongs to the distance interval corresponding to the antigen, it indicates that the antigen fluorescence image has a specific light spot. If a certain antigen fluorescence image of an abnormal solution has a specific light spot, it indicates that the standard concentration abnormal solution has the abnormal body. If the abnormal bodies of the standard concentration diluted solution of a certain abnormal solution are the same as the abnormal bodies of the abnormal solution, it indicates that the initial specific chromatography test of the abnormal solution is accurate and there is no need to dilute the specific chromatography test. The sizes of each specific light spot of each solution accurately obtained by the initial specific chromatography test are collected, and the sizes of each specific light spot of each solution accurately obtained by the initial specific chromatography test are substituted into the concentration calculation formula. , the concentration of abnormal substance b in abnormal solution a is obtained , a is the abnormal solution number, , , b is an abnormal body, , , and are the spot size and mobile phase wetted test paper size of the initial specific chromatography test of abnormal body b of abnormal solution a, respectively. is the preset concentration correction factor, and The volume and mass of the solution used for the initial specific chromatography test of abnormal body b of abnormal solution a, and The volume of the solution after dilution and the volume of the solution before dilution are respectively preset for abnormal solution a.
[0030] It should be noted that the concentration correction factor is set by the staff, for example 1.5.
[0031] In a specific embodiment, the dilution specific chromatography test is performed, and the specific testing process is as follows: each abnormal solution is diluted at each dilution ratio to obtain each diluted solution of each abnormal solution, and a specific chromatography test is performed to obtain various antigen fluorescence images of each diluted solution of each abnormal solution, and the fluorescence brightness and distance of each light spot are obtained from the various antigen fluorescence images. According to the fluorescence brightness and distance of each light spot on the various antigen fluorescence images of each diluted solution of each abnormal solution, judgment is made to obtain each abnormal body of each diluted solution of each abnormal solution and the spot size corresponding to each abnormal body.
[0032] In a specific embodiment, the specific test data of each dilution of each abnormal solution are analyzed, and the specific analysis results are as follows: the specific test data of each dilution of each abnormal solution includes each abnormal body of each dilution of each abnormal solution and the spot size corresponding to each abnormal body, and the abnormal bodies of each dilution of each abnormal solution are counted to obtain the number of occurrences of each abnormal body of each abnormal solution, and the size of each specific spot of each dilution of each solution is substituted into the calculation formula The concentration of the abnormal body b of the c-diluted solution of the abnormal solution a is obtained, where c is the number of the diluted solution. , , and They are the spot size and mobile phase wetted test paper size for the abnormal solution a, the abnormal solution c, and the abnormal solution b dilution specific chromatography test, respectively. and The volume and mass of the solution used for the dilution of abnormal solution a and abnormal substance b in the specific chromatography test are as follows: and are the volume of the diluted solution and the volume of the solution before dilution corresponding to the dilution solution c of abnormal solution a, respectively. The spot size of the abnormal body b tested for the abnormal solution a c dilution solution, The volume of solution used for the abnormal solution a, the abnormal solution b, and the dilution solution c. and They are respectively the volume of the diluted solution after dilution and the volume of the dilution solution before dilution of the c dilution solution of the abnormal solution a. The standard concentration corresponding to each abnormal body is obtained from the database. If the concentration of a certain abnormal body of a certain dilution solution of a certain solution is greater than the standard concentration, it indicates that the concentration of the abnormal body of the dilution solution of the solution is high concentration. The number of occurrences of high concentration of each abnormal body of each abnormal solution is obtained by statistics.
[0033] The number of occurrences of each abnormal body and the number of high concentration occurrences of each abnormal solution are input into the solution-specific model to obtain the output results of each abnormal solution. If the output result of each abnormal solution is 1, it indicates that the dilution-specific test of the abnormal body of the abnormal solution is accurate. If the output result is 0, it indicates that the dilution-specific test of the abnormal body of the abnormal solution is inaccurate, and the dilution solution is replaced to continue the dilution-specific chromatography test.
[0034] In a specific embodiment, the solution-specific model is specifically set up as follows: the number of occurrences of each abnormal body and the number of occurrences of high concentrations of each abnormal solution are input into the solution-specific model: , and obtain the output results of each abnormal solution , a is the abnormal solution number, , , b is an abnormal body, , , and are the number of occurrences of abnormal body b and the number of occurrences of high concentration in abnormal solution a, respectively. A and B are the number of occurrences of the preset standard abnormal body and the number of occurrences of high concentration, respectively. and are the weight factors of the number of occurrences of the preset standard abnormal body and the number of occurrences of the high concentration, , , , C is the standard test precision index.
[0035] It should be noted that the preset number of standard abnormal body occurrences and the number of high concentration occurrences are set by the staff, for example, the number of standard abnormal body occurrences is 8 times and the number of high concentration occurrences is 1 time, and the weight factor of the standard abnormal body occurrence number and the weight factor of the high concentration occurrence number are set by the staff, for example, the weight factor of the standard abnormal body occurrence number is 0.3 and the weight factor of the high concentration occurrence number is 0.7.
[0036] In a specific embodiment, the basic data of the solution, the type of abnormal body and the concentration of the abnormal body of each abnormal solution are analyzed, and the specific analysis process is as follows: the basic data of the solution includes the standard concentration and maximum concentration corresponding to each abnormal body, and the standard concentration corresponding to each abnormal body is input into the solution abnormal model to obtain the output result of each solution. If the output result of a solution is 1, and the concentration of each abnormal body of the solution is less than the corresponding maximum concentration of each abnormal body, it indicates that the solution meets the requirements. If the output result of a solution is 0, or the concentration of a certain abnormal body of the solution is greater than or equal to the corresponding maximum concentration of each abnormal body, it indicates that the solution is abnormal and a warning is issued.
[0037] In a specific embodiment, the solution anomaly model is specifically set up as follows: the standard concentration corresponding to each anomaly is input into the solution anomaly model: , and get the output result of abnormal solution a , and are the concentration of abnormal substance b in abnormal solution a and the preset standard concentration corresponding to abnormal substance b, a is the abnormal solution number, , , b is an abnormal body, , , is the weight factor of the preset abnormal body b concentration, , , N is the abnormal index of the standard solution.
[0038] It should be noted that the preset standard concentrations corresponding to each abnormal body are set by the staff, for example, the standard concentration corresponding to a certain abnormal body is 10000 cfu / g, and the preset weighting factors of each abnormal body concentration are set by the staff, for example, the weighting factor of a certain abnormal body concentration is 0.08.
[0039] The above contents are merely examples and explanations of the concept of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the concept of the invention or exceed the scope defined in this specification, they shall all fall within the protection scope of the present invention.
Claims
1. A method for processing fluorescent immunochromatography test data, characterized in that: The steps include: Step 1, basic chromatography test: perform basic chromatography test on each test object to obtain fluorescence images of each solution, and then collect basic chromatography information of each solution from the fluorescence images of each solution, analyze the basic chromatography information of each solution to obtain each abnormal solution, and identify each abnormal body of each abnormal solution from each abnormal solution; Step 2, specific chromatography test: according to each abnormal body of each abnormal solution, set the initial specific chromatography test, collect each specific test data of the standard concentration of each abnormal solution, and then determine whether the dilution specific chromatography test is needed. When the dilution specific chromatography test is performed, collect each specific test data of each diluted solution of each abnormal solution, and analyze each specific test data of each diluted solution of each abnormal solution according to the solution-specific model to obtain the type and concentration of the abnormal body of each abnormal solution; Step 3: Chromatographic data analysis: Obtain basic solution data from the database, and analyze the basic solution data, the type of abnormal body and the concentration of abnormal body in each abnormal solution according to the solution abnormality model to determine whether an early warning is needed.
2. The method for processing fluorescent immunochromatography test data according to claim 1, characterized in that: The basic chromatography information of each solution is collected, and the specific collection process is as follows: The basic chromatographic information of each solution includes the distance and fluorescence brightness of each light spot in each solution; The types of each analyte are obtained from a database, and a fixed plate for detecting antigens is selected according to the types of each analyte, each analyte is made into a solution, and then a part of the solution of each analyte is washed into the fixed plate, and after chromatography, a fluorescence image of each basic chromatography solution is obtained through a fluorescence observation device, and basic chromatography information of each solution is obtained from the fluorescence image of each basic chromatography solution; The fluorescence image of each basic chromatography solution is obtained by fluorescence recognition technology to obtain the distance and fluorescence brightness of each light spot to the test line. The shortest distance from each light spot to the test line is selected and recorded as the distance of each light spot, thereby obtaining the distance and fluorescence brightness of each light spot in each solution.
3. The method for processing fluorescent immunochromatography test data according to claim 2, characterized in that: The basic chromatography information of each solution is analyzed, and the specific analysis process is as follows: The fluorescence brightness and distance of each light spot of the standard solution are obtained from the database, and the fluorescence brightness and distance of each light spot of the standard solution are substituted into the calculation formula to obtain the brightness deviation value and the distance deviation value between each light spot of the standard solution. If the brightness deviation value of a pair of light spots of the standard solution is less than the preset light spot deviation value and the distance deviation value is less than the preset distance deviation value, it indicates that the pair of light spots of the standard solution are the same type of normal light spots, thereby obtaining various types of normal light spots, and the fluorescence brightness and distance of each light spot of the standard solution are statistically analyzed to obtain each fluorescence brightness and each distance of each type of normal light spot; The maximum fluorescence brightness and the minimum fluorescence brightness of each type of normal light spot are recorded as the upper limit and the lower limit of the fluorescence brightness interval, respectively, to obtain the fluorescence brightness interval of each type of normal light spot. The shortest distance and the minimum distance of each type of normal light spot are recorded as the upper limit and the lower limit of the distance interval, respectively, to obtain the distance interval of each type of normal light spot. If the fluorescence brightness of a certain light spot does not belong to the fluorescence brightness interval of various types of normal light spots, or the fluorescence brightness of the light spot does not belong to the distance interval of various types of normal light spots, it indicates that the light spot is a specific light spot. If a certain light spot of a certain solution is a specific light spot, then the solution is recorded as an abnormal solution, and the fluorescence brightness interval of each type of specific light spot is obtained from the database. If the fluorescence brightness of a certain light spot of an abnormal solution belongs to the fluorescence brightness interval of a certain type of specific light spot, it indicates that the abnormal solution has an abnormal body corresponding to the specific light spot, thereby obtaining each abnormal body of each abnormal solution.
4. The method for processing fluorescent immunochromatography test data according to claim 1, characterized in that: The initial specific chromatography test is set up, and the specific setting process is as follows: Each abnormal solution is diluted at a preset dilution ratio to obtain a dilution solution of a standard concentration of each abnormal solution. A corresponding antigen fixing plate is selected according to each abnormal body of each abnormal solution to obtain various antigen fixing plates of each abnormal solution. The dilution solution of the standard concentration of each abnormal solution is flowed into the corresponding various antigen fixing plates to obtain various antigen fluorescence images of each abnormal solution.
5. The method for processing fluorescent immunochromatography test data according to claim 1, characterized in that: The specific judgment process of determining whether a dilution specific chromatography test is required is as follows: The specific test data of the standard concentration of each abnormal solution include the fluorescence brightness and distance of each light spot in each antigen fluorescence image of each standard concentration abnormal solution. If the fluorescence brightness of any light spot in a certain antigen fluorescence image belongs to the fluorescence brightness interval corresponding to the antigen, and the distance of the light spot belongs to the distance interval corresponding to the antigen, it indicates that the antigen fluorescence image has a specific light spot. If a certain antigen fluorescence image of an abnormal solution has a specific light spot, it indicates that the standard concentration abnormal solution has the abnormal body. If the abnormal bodies of the standard concentration diluted solution of an abnormal solution are the same as the abnormal bodies of the abnormal solution, it indicates that the initial specific chromatography test of the abnormal solution is accurate, and there is no need to dilute the specific chromatography test. The sizes of each specific light spot of each solution accurately obtained by the initial specific chromatography test are collected, and the sizes of each specific light spot of each solution accurately obtained by the initial specific chromatography test are substituted into the concentration calculation formula to obtain the concentration of each abnormal body of each solution.
6. The method for processing fluorescent immunochromatography test data according to claim 1, characterized in that: The dilution specific chromatography test is performed, and the specific test process is as follows: Each abnormal solution is diluted at a different dilution ratio to obtain each diluted solution of each abnormal solution, and a specific chromatography test is performed to obtain various antigen fluorescence images of each diluted solution of each abnormal solution, and the fluorescence brightness and distance of each light spot are obtained from the various antigen fluorescence images. According to the fluorescence brightness and distance of each light spot on the various antigen fluorescence images of each diluted solution of each abnormal solution, judgment is made to obtain each abnormal body of each diluted solution of each abnormal solution and the spot size corresponding to each abnormal body.
7. The method for processing fluorescent immunochromatography test data according to claim 1, characterized in that: The specific test data of each dilution solution of each abnormal solution are analyzed, and the specific analysis results are as follows: The specific test data of each dilution of each abnormal solution include each abnormal body of each dilution of each abnormal solution and the spot size corresponding to each abnormal body. The abnormal bodies of each dilution of each abnormal solution are counted to obtain the number of occurrences of each abnormal body of each abnormal solution. The size of each specific spot of each dilution of each solution is substituted into the calculation formula to obtain the concentration of each abnormal body of each dilution of each abnormal solution. The standard concentration corresponding to each abnormal body is obtained from the database. If the concentration of a certain abnormal body of a certain dilution of a certain solution is greater than the standard concentration, it indicates that the concentration of the abnormal body of the dilution of the solution is high concentration. The number of occurrences of high concentration of each abnormal body of each abnormal solution is counted. The number of occurrences of each abnormal body and the number of high concentration occurrences of each abnormal solution are input into the solution-specific model to obtain the output results of each abnormal solution. If the output result of each abnormal solution is 1, it indicates that the dilution-specific test of the abnormal body of the abnormal solution is accurate. If the output result is 0, it indicates that the dilution-specific test of the abnormal body of the abnormal solution is inaccurate, and the dilution solution is replaced to continue the dilution-specific chromatography test.
8. The method for processing fluorescent immunochromatography test data according to claim 7, characterized in that: The specific setting process of the solution-specific model is as follows: The number of occurrences of each abnormal body and the number of high concentration occurrences of each abnormal solution are input into the solution-specific model: , and obtain the output results of each abnormal solution , a is the abnormal solution number, , , b is an abnormal body, , , and are the number of occurrences of abnormal body b and the number of occurrences of high concentration in abnormal solution a, respectively. A and B are the number of occurrences of the preset standard abnormal body and the number of occurrences of high concentration, respectively. and are the weight factors of the number of occurrences of the preset standard abnormal body and the number of occurrences of the high concentration, , , , C is the standard test precision index.
9. The method for processing fluorescent immunochromatography test data according to claim 1, characterized in that: The basic data of the solution, the types of abnormal bodies and the concentrations of abnormal bodies in each abnormal solution are analyzed. The specific analysis process is as follows: The basic data of the solution include the standard concentration and maximum concentration corresponding to each abnormal body. The standard concentration corresponding to each abnormal body is input into the solution abnormal model to obtain the output result of each solution. If the output result of a solution is 1, and the concentration of each abnormal body of the solution is less than the corresponding maximum concentration of each abnormal body, it indicates that the solution meets the requirements. If the output result of a solution is 0, or the concentration of a certain abnormal body of the solution is greater than or equal to the corresponding maximum concentration of each abnormal body, it indicates that the solution is abnormal and a warning is issued.
10. The method for processing fluorescent immunochromatography test data according to claim 9, characterized in that: The specific setting process of the solution abnormality model is as follows: Input the standard concentration corresponding to each anomaly into the solution anomaly model: , and get the output result of abnormal solution a , and are the concentration of abnormal substance b in abnormal solution a and the preset standard concentration corresponding to abnormal substance b, a is the abnormal solution number, , , b is an abnormal body, , , is the weight factor of the preset abnormal body b concentration, , , N is the abnormal index of the standard solution.
Citation Information
Patent Citations
Fluorescence immunochromatography test data processing method
CN107389625A
Analysis method and device of immunofluorescence chromatography curve and electronic equipment
CN113761456A
Automatic analyzer
CN1148177A
Fluorescence immunochromatography test strip and quantitative analysis method
CN117007814A
Abnormity early warning method and system for hydraulic lubricating system for leakage detection
CN118757482A
